Ansell Limited (ASX:ANN)
Australia · Delayed Price · Currency is AUD 28.99
+0.03 (0.10%)
Jun 11, 2026, 4:11 PM AEST
Ansell Market Cap
Ansell has a market cap or net worth of 4.03 billion as of June 11, 2026. Its market cap has decreased by -11.48% in one year.
Market Cap
4.03B
Enterprise Value
4.95B
Revenue
3.01B
Ranking
n/a
PE Ratio
20.79
Stock Price
28.99
Market Cap Chart
Since January 16, 1992, Ansell's market cap has decreased from 5.00B to 4.03B, a decrease of -19.27%. That is a compound annual growth rate of -0.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 4.03B | -19.16% |
| Dec 31, 2025 | 4.99B | 1.96% |
| Dec 31, 2024 | 4.89B | 56.70% |
| Dec 29, 2023 | 3.12B | -12.08% |
| Dec 30, 2022 | 3.55B | -11.25% |
| Dec 31, 2021 | 4.00B | -10.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 49.96B |
| Sigma Healthcare | 31.75B |
| Pro Medicus | 16.88B |
| Sonic Healthcare | 10.02B |
| Ramsay Health Care | 8.84B |
| Cochlear | 6.71B |
| Telix Pharmaceuticals | 4.59B |
| Mesoblast | 2.60B |